Results 161 to 170 of about 142,764 (336)

The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients

British Journal of Pharmacology, EarlyView.
Background and Purpose Novel heart failure (HF) pharmacotherapies, including angiotensin receptor‐neprilysin inhibitor (ARNI) and sodium‐glucose cotransporter 2 inhibitors (SGLT2is), may confer cardiovascular benefits by attenuating myocardial fibrosis. However, direct evidence from human failing myocardial samples is limited.
Dávid Nagy, Tamás Radovits, Tímea Bálint, Zoltán Horváth, Petra Kocsis‐Balogh, Ákos Gergely Tóth, Attila Oláh, Alex Ali Sayour, Bálint András Barta, Béla Merkely, Mihály Ruppert   +10 more
wiley   +1 more source

Synthetic atrial natriuretic factor does not dilate resistance-sized arteries. [PDF]

, 1986
George Osol, W Halpern, Belay Tesfamariam, K Nakayama, Daniel I. Weinberg   +4 more
openalex   +1 more source

Intracellular control of renin release - an overview [PDF]

, 1986
Kurtz, Armin
core   +1 more source

Comparative effectiveness of pharmacotherapy for heart failure with preserved ejection fraction: A systematic review and network meta‐analysis

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Heart failure with preserved ejection fraction (HFpEF) presents a therapeutic challenge, characterised by a paucity of validated treatments. Emerging data suggest that targeting adiposity is central to HFpEF pathogenesis. We conducted an updated network meta‐analysis to compare the efficacy of emerging and established HFpEF therapies ...
Szu‐Han Chen, Yu‐Wen Tseng, Chi‐Jung Huang, Shu‐Mei Yang, Marat Fudim, Shao‐Yuan Chuang, Shih‐Hsien Sung, Hao‐Min Cheng   +7 more
wiley   +1 more source

ATRIAL NATRIURETIC FACTOR IN BILHARZIAL HEPATIC FIBROSIS AND POSTHEPATITiC CIRRHOSIS [PDF]

, 1992
Hanan H. Rizk, Amina Mohamed Mahmoud Badr, Mamun Sarhan., M EI-Rakhawy, Enayat Hashem, Maram Magdy Shaat   +5 more
openalex   +1 more source

Baseline and stimulated ANF plasma levels [PDF]

, 1987
Arendt, Rainer M., Erdmann, E., Gerbes, Alexander L., Glatthor, C., Kemkes, B., Kramer, Herbert J., Riedel, Angelika, Ritter, D., Schimak, M., Stangl, E., Zähringer, J.   +10 more
core   +1 more source

Sacubitril/Valsartan Attenuates Inflammation and Fibrosis Associated With Decreased Integrin α8 and Inhibits Hepatocarcinogenesis in a Rat Model of Metabolic Dysfunction‐Associated Steatohepatitis

Hepatology Research, EarlyView.
Sacubitril/Valsartan (Sac/Val) alleviates fibrosis and inflammation in metabolic dysfunction‐associated steatohepatitis (MASH). Its anti‐fibrotic effect is linked to the suppression of Integrin alpha 8 (Itga8), a protein crucial for hepatic stellate cell (HSC) activation and collagen production.
Hayato Kawamura, Aya Naiki‐Ito, Xiaochen Kuang, Akihiro Murakami, Masayuki Komura, Takanori Suzuki, Hiroyuki Kato, Yuko Nagayasu, Kentaro Matsuura, Kei Fujiwara, Hiromi Kataoka, Satoru Takahashi   +11 more
wiley   +1 more source

Ganglionic immunoreactive atrial natriuretic factor in rat experimental hypertension. [PDF]

, 1988
Otto Kuchel, Waldemar Debinski, Nguyen T. Buu, M. Cantin, Jacques Genest   +4 more
openalex   +1 more source

Atrial natriuretic factor in human blood.

Journal of Clinical Investigation, 1985
T. Yamaji, M. Ishibashi, F. Takaku
semanticscholar   +1 more source

Phenotyping of acute heart failure with preserved ejection fraction: real‐world outcomes in a cohort of older patients

Internal Medicine Journal, EarlyView.
Abstract Background Previous studies have identified distinct subgroups (phenogroups) of patients with heart failure with preserved ejection fraction (HFpEF). Aims This study aims to identify distinct phenotypes in older patients with HFpEF hospitalised for acute heart failure (AHF) and investigate the relationship between subgroups and outcomes ...
Maria Livia Burzo *, Giuseppe De Matteis, Amato Serra, Davide Antonio Della Polla, Mariella Fuorlo, Maria Anna Nicolazzi, Benedetta Simeoni, Antonio Gasbarrini, Francesco Franceschi, Giovanni Gambassi, Marcello Covino   +10 more
wiley   +1 more source